Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1018476.RAv80UwWqgY5app0YfXOFqY4wTJE-_xoM6IJ--slEsAV0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1018476.RAv80UwWqgY5app0YfXOFqY4wTJE-_xoM6IJ--slEsAV0130_assertion type Assertion NP1018476.RAv80UwWqgY5app0YfXOFqY4wTJE-_xoM6IJ--slEsAV0130_head.
- NP1018476.RAv80UwWqgY5app0YfXOFqY4wTJE-_xoM6IJ--slEsAV0130_assertion description "[However, no association was found between CBS methylation or KRAS mutations with cancer relapse/metastasis in Stage II CRC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1018476.RAv80UwWqgY5app0YfXOFqY4wTJE-_xoM6IJ--slEsAV0130_provenance.
- NP1018476.RAv80UwWqgY5app0YfXOFqY4wTJE-_xoM6IJ--slEsAV0130_assertion evidence source_evidence_literature NP1018476.RAv80UwWqgY5app0YfXOFqY4wTJE-_xoM6IJ--slEsAV0130_provenance.
- NP1018476.RAv80UwWqgY5app0YfXOFqY4wTJE-_xoM6IJ--slEsAV0130_assertion SIO_000772 23152928 NP1018476.RAv80UwWqgY5app0YfXOFqY4wTJE-_xoM6IJ--slEsAV0130_provenance.
- NP1018476.RAv80UwWqgY5app0YfXOFqY4wTJE-_xoM6IJ--slEsAV0130_assertion wasDerivedFrom befree-20150227 NP1018476.RAv80UwWqgY5app0YfXOFqY4wTJE-_xoM6IJ--slEsAV0130_provenance.
- NP1018476.RAv80UwWqgY5app0YfXOFqY4wTJE-_xoM6IJ--slEsAV0130_assertion wasGeneratedBy ECO_0000203 NP1018476.RAv80UwWqgY5app0YfXOFqY4wTJE-_xoM6IJ--slEsAV0130_provenance.